{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:22:33Z","timestamp":1792750953961,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.ijpharm.2012.02.015","type":"journal-article","created":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T21:03:26Z","timestamp":1330031006000},"page":"284-292","source":"Crossref","is-referenced-by-count":68,"title":["Design of a long-term antipsychotic in situ forming implant and its release control method and mechanism"],"prefix":"10.1016","volume":"427","author":[{"given":"Lexi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.02.015_bib0005","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijpharm.2007.04.034","article-title":"Influence of end groups on in vitro release and biological activity of lysozyme from a phase-sensitive smart polymer-based in situ gel forming controlled release drug delivery system","volume":"342","author":"Chhabra","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0928-0987(01)00095-1","article-title":"Modeling and comparison of dissolution profiles","volume":"13","author":"Costa","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2007.06.013","article-title":"An investigation into the influence of drug lipophilicity on the in vivo absorption profiles from subcutaneous microspheres and in situ forming depots","volume":"122","author":"Deadman","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0020","unstructured":"Dunn, R.L., 1990. Biodegradable in-situ forming implants and methods of producing the same, United States."},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-3659(98)00158-8","article-title":"Phase inversion dynamics of PLGA solutions related to drug delivery","volume":"58","author":"Graham","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-3659(02)00008-1","article-title":"Biodegradable injectable in situ forming drug delivery systems","volume":"80","author":"Hatefi","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0035","first-page":"168","article-title":"Recent advances in implantable drug delivery","volume":"4","author":"Solanki","year":"2010","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0040","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2009.09.012","article-title":"Drug release from PLGA-based microparticles: effects of the microparticle:bulk fluid ratio","volume":"383","author":"Klose","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0045","series-title":"Highly Selective Neurotoxins: Basic and Clinical Applications","author":"Kostrzewa","year":"1998"},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0168-3659(94)00083-7","article-title":"Development of an in situ forming biodegradable poly-lactide-coglycolide system for the controlled release of proteins","volume":"33","author":"Lambert","year":"1995","journal-title":"J. Control. Release"},{"issue":"141","key":"10.1016\/j.ijpharm.2012.02.015_bib0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s002130050844","article-title":"Can the state-dependency hypothesis explain prevention of amphetamine sensitization in rats by NMDA receptor antagonists?","volume":"361","author":"Li","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0060","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2010.07.015","article-title":"In vitro and in vivo study of thymosin alpha1 biodegradable in situ forming poly(lactide-co-glycolide) implants","volume":"397","author":"Liu","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0110","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1002\/jps.21091","article-title":"Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release","volume":"96","author":"Lu","year":"2007","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0115","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejpb.2007.05.016","article-title":"In vivo evaluation of risperidone-SAIB in situ system as a sustained release delivery system in rats","volume":"68","author":"Lu","year":"2008","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejps.2005.09.002","article-title":"In situ forming microparticle system for controlled delivery of leuprolide acetate: influence of the formulation and processing parameters","volume":"27","author":"Luan","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0070","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jconrel.2005.10.005","article-title":"Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems","volume":"110","author":"Luan","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2008.04.004","article-title":"In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting","volume":"129","author":"Martinez","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0376-7388(95)00046-F","article-title":"The dynamics of diffusion and gel growth during nonsolvent-induced phase inversion of polyethersulfone","volume":"105","author":"McHugh","year":"1995","journal-title":"J. Membr. Sci."},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0085","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jconrel.2010.08.020","article-title":"Effect of injection site on in situ implant formation and drug release in vivo","volume":"147","author":"Patel","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejpb.2007.10.009","article-title":"Myotoxicity studies of O\/W-in situ forming microparticle systems","volume":"69","author":"Rungseevijitprapa","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/10837451003739297","article-title":"Biodegradable poly(d,l-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: zero-order release formulation","volume":"16","author":"Su","year":"2011","journal-title":"Pharma. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1742-7843.2010.00552.x","article-title":"Studies on the acute toxicity pharmacokinetics and pharmacodynamics of paliperidone derivatives \u2013 comparison to paliperidone and risperidone in mice and rats","volume":"107","author":"Sun","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ijpharm.2012.02.015_bib0105","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1176\/appi.ajp.159.4.657","article-title":"An animal model of Tourette's syndrome","volume":"159","author":"Taylor","year":"2002","journal-title":"Am. J. Psychiatry"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312001482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312001482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T22:24:32Z","timestamp":1543184672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312001482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0378517312001482"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.02.015","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}